Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curio Bioscience is a spatial biology company that develops high-precision tools for genomics research, enabling the mapping of the whole transcriptome at high resolution within its native tissue context. The company's flagship product, Curio Seeker, is the first commercial spatial transcriptomics kit based on the Slide-seq method, providing 10-micron resolution without the need for specialized instrumentation. Curio also offers Curio Trekker, a single-cell spatial mapping kit that transforms single-cell sequencing data into spatially resolved maps. In January 2025, Curio Bioscience was acquired by Takara Bio to integrate its innovative spatial genomics platforms into Takara's global single-cell omics portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curio Spice.